These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 20345171)

  • 1. A medicinal chemist's guide to molecular interactions.
    Bissantz C; Kuhn B; Stahl M
    J Med Chem; 2010 Jul; 53(14):5061-84. PubMed ID: 20345171
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramolecular hydrogen bonding in medicinal chemistry.
    Kuhn B; Mohr P; Stahl M
    J Med Chem; 2010 Mar; 53(6):2601-11. PubMed ID: 20175530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A medicinal chemistry perspective on structure-based drug design and development.
    Maddaford SP
    Methods Mol Biol; 2012; 841():351-81. PubMed ID: 22222460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial preface.
    Nilsson L; Åqvist J
    Biochim Biophys Acta; 2015 May; 1850(5):859-860. PubMed ID: 25615536
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for Late-Stage Optimization: Profiling Thermodynamics by Preorganization and Salt Bridge Shielding.
    Sandner A; Hüfner-Wulsdorf T; Heine A; Steinmetzer T; Klebe G
    J Med Chem; 2019 Nov; 62(21):9753-9771. PubMed ID: 31633354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of Hydrogen Bonding Patterns in Ligand-Free, Lactose- and Glycerol-Bound Galectin-3C by Neutron Crystallography to Guide Drug Design.
    Manzoni F; Wallerstein J; Schrader TE; Ostermann A; Coates L; Akke M; Blakeley MP; Oksanen E; Logan DT
    J Med Chem; 2018 May; 61(10):4412-4420. PubMed ID: 29672051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of molecular dynamics on drug design: applications for the characterization of ligand-macromolecule complexes.
    Mortier J; Rakers C; Bermudez M; Murgueitio MS; Riniker S; Wolber G
    Drug Discov Today; 2015 Jun; 20(6):686-702. PubMed ID: 25615716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physics-based methods for studying protein-ligand interactions.
    Huang N; Jacobson MP
    Curr Opin Drug Discov Devel; 2007 May; 10(3):325-31. PubMed ID: 17554859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydration properties of ligands and drugs in protein binding sites: tightly-bound, bridging water molecules and their effects and consequences on molecular design strategies.
    García-Sosa AT
    J Chem Inf Model; 2013 Jun; 53(6):1388-405. PubMed ID: 23662606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational approaches to improving selectivity in drug design.
    Huggins DJ; Sherman W; Tidor B
    J Med Chem; 2012 Feb; 55(4):1424-44. PubMed ID: 22239221
    [No Abstract]   [Full Text] [Related]  

  • 12. The role and significance of unconventional hydrogen bonds in small molecule recognition by biological receptors of pharmaceutical relevance.
    Tóth G; Bowers SG; Truong AP; Probst G
    Curr Pharm Des; 2007; 13(34):3476-93. PubMed ID: 18220785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore modelling: a forty year old approach and its modern synergies.
    Caporuscio F; Tafi A
    Curr Med Chem; 2011; 18(17):2543-53. PubMed ID: 21568893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chirality and its importance in drug development: a synthetic chemist's perspective.
    Roberts SM
    Biochem Soc Trans; 1991 Apr; 19(2):446-53. PubMed ID: 1889627
    [No Abstract]   [Full Text] [Related]  

  • 17. In silico identification of bioisosteric functional groups.
    Ertl P
    Curr Opin Drug Discov Devel; 2007 May; 10(3):281-8. PubMed ID: 17554854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the determination of the binding modes of non-standard ligands in X-ray crystal complexes.
    Malde AK; Mark AE
    J Comput Aided Mol Des; 2011 Jan; 25(1):1-12. PubMed ID: 21053051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology.
    Huber W; Mueller F
    Curr Pharm Des; 2006; 12(31):3999-4021. PubMed ID: 17100609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Roles of Water in the Protein Matrix: A Largely Untapped Resource for Drug Discovery.
    Spyrakis F; Ahmed MH; Bayden AS; Cozzini P; Mozzarelli A; Kellogg GE
    J Med Chem; 2017 Aug; 60(16):6781-6827. PubMed ID: 28475332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.